InflammX Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://inflammx.com
Study of Xiflamâ„¢ Treatment in Patients Post COVID-19 Infection Suffering from What is Known As Long COVID (LC)
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Inflammx Therapeutics Inc
- Target Recruit Count
- 15
- Registration Number
- NCT06437223
- Locations
- 🇺🇸
Massachusetts Eye Research and Surgery Institution (MERSI), Waltham, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath